EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells

Yasmine Kemkem, Mark Quinn iD, Bence Kövér, Alice Santambrogio, James Kaufman-Cook, Olivia Sherwin, Laura D Scriba, Dimitria Brempou, Miriam Vazquez Segoviano, Dylan Cameron, Ilona Berger, Wen Ng und 11 weitere

Endocrine-Related Cancer · 2026

DOI: 10.1530/erc-25-0242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Yasmine Kemkem und 22 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Craniofacial and Regenerative Biology, King's College London, London, United Kingdom. Hauptthemen laut MEDLINE: Pheochromocytoma, Adrenal Gland Neoplasms, Paraganglioma, Neoplastic Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phaeochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumours that arise in the neural crest (NC)-derived adrenal medulla and the paraganglia, respectively. Approximately 10–15% of patients with PCCs and 35–40% with PGLs go on to develop metastatic disease, leading to a reported median overall survival of 7 years. The development of prognostic markers and subsequent personal therapeutic strategies are hindered by a lack of understanding of tumourigenesis. In other organs, cells with stem-like properties are at the root of tumour initiation and maintenance, due to their ability to self-renew and give rise to differentiated cells. We have recently shown that, in the human adrenal, a subset of sustentacular cells, endowed with a support role, are in fact SOX2+ postnatal adrenomedullary stem cells that are specified along the NC migratory route. In this study, we intended to determine if SOX2+ cells in PCCs and PGLs can behave as tumour-initiating stem cells. Using expression and transcriptomic studies, we demonstrate the presence of SOX2/SOX2-expressing cells across a broad range of PCCs and PGLs, irrespective of tumour aggressiveness, location, and causative mutation. In silico analyses reveal the co-expression of SOX2 and chromaffin cell markers in the tumour and reveal the active proliferation of these double-positive cells. Isolation of these cells in vitro in stem cell-promoting media, and their xenotransplantation on chicken chorioallantoic membranes, demonstrates that they have the potential to expand and metastasise in ovo, supporting their potential as tumour-initiating cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaAdrenal Gland NeoplasmsParagangliomaNeoplastic Stem CellsSOXB1 Transcription FactorsHumansAnimals

Stichwörter der Autor:innen

PCCPGLPPGLSOX2cancer stem cellsparagangliomaphaeochromocytomastem cellssustentacular cellstumour-initiating cells

Substanzen

SOXB1 Transcription FactorsSOX2 protein, human

Autor:innen und Institutionen

  • Centre for Craniofacial and Regenerative Biology, King's College London, London, United Kingdom.
  • Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
  • Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Guy's & St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Medizinische Klinik Und Poliklinik IV, LMU Klinikum, LMU München, Munich, Germany.

ORCID-Profile: Mark Quinn, Marily Theodoropoulou, Christina Pamporaki, Cynthia L Andoniadou

Zitieren

APA

Kemkem, Y., Quinn, M., Kövér, B., Santambrogio, A., Kaufman-Cook, J., Sherwin, O., Scriba, L. D., Brempou, D., Segoviano, M. V., Cameron, D., Berger, I., Ng, W., Nonaka, D., Theodoropoulou, M., Pamporaki, C., Carroll, P. V., Izatt, L., Chapple, J. P., Bornstein, S. R., …, & Andoniadou, C. L. (2026). Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0242

Vancouver

Kemkem Y, Quinn M, Kövér B, Santambrogio A, Kaufman-Cook J, Sherwin O, et al. Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells. Endocrine-Related Cancer. 2026. doi:10.1530/erc-25-0242

BibTeX
@article{Kemkem2026,
  author = {Kemkem, Yasmine and Quinn, Mark and Kövér, Bence and Santambrogio, Alice and Kaufman-Cook, James and Sherwin, Olivia and Scriba, Laura D and Brempou, Dimitria and Segoviano, Miriam Vazquez and Cameron, Dylan and Berger, Ilona and Ng, Wen and Nonaka, Daisuke and Theodoropoulou, Marily and Pamporaki, Christina and Carroll, Paul V and Izatt, Louise and Chapple, J Paul and Bornstein, Stefan R and Bechmann, Nicole and Steenblock, Charlotte and Oakey, Rebecca J and Andoniadou, Cynthia L},
  title = {Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  doi = {10.1530/erc-25-0242}
}
Kostenlos starten →